|
UBE2R2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.646200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.270400E-02 |
| Normal-vs-Stage2 |
2.569800E-01 |
| Normal-vs-Stage3 |
2.638200E-01 |
| Normal-vs-Stage4 |
7.305500E-02 |
| Stage1-vs-Stage2 |
8.146000E-01 |
| Stage1-vs-Stage3 |
7.474200E-01 |
| Stage1-vs-Stage4 |
4.816800E-01 |
| Stage2-vs-Stage3 |
6.828400E-01 |
| Stage2-vs-Stage4 |
7.510600E-01 |
| Stage3-vs-Stage4 |
3.860600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.218000E-02 |
| Normal-vs-AfricanAmerican |
6.000600E-04 |
| Normal-vs-Asian |
6.908100E-02 |
| Caucasian-vs-AfricanAmerican |
3.787800E-02 |
| Caucasian-vs-Asian |
6.166800E-01 |
| AfricanAmerican-vs-Asian |
5.661900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.214500E-02 |
| Normal-vs-Female |
1.091620E-01 |
| Male-vs-Female |
3.487200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.864000E-02 |
| Normal-vs-Age(41-60Yrs) |
9.551600E-02 |
| Normal-vs-Age(61-80Yrs) |
2.333400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.302800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.126200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.183000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.743830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.593400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.902160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.687400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.016000E-01 |
| Classical-VS-Follicular |
9.717200E-03 |
| Classical-VS-Other |
8.567800E-01 |
| Classical-VS-Normal |
6.757100E-03 |
| Tall-VS-Follicular |
4.340100E-02 |
| Tall-VS-Other |
8.102600E-01 |
| Tall-VS-Normal |
4.934300E-02 |
| Follicular-VS-Other |
5.040000E-01 |
| Follicular-VS-Normal |
6.983200E-01 |
| Other-VS-Normal |
6.051600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.472400E-01 |
| Normal-vs-N1 |
8.405000E-01 |
| N0-vs-N1 |
2.987000E-01 |
|
|
